Knowde Enhanced TDS
Identification & Functionality
- INCI Name
- Cosmetic Ingredients Functions
- Technologies
Features & Benefits
- Benefit Claims
- Product Features
- Broad spectrum cosmetic preservative
- Efficacy booster for antimicrobials
- Antimicrobial stabilizer in combination with other cosmetic ingredients.
- Globally approved
- Stable at high temperature & pH
- Effective in acidic pH
- Moisturizer and emollient
- Mode of Action
New AE Protek NPB effectively reduces the surface tension of water, thus the wetting of surface is improved. This phenomenon makes the mixture of phenoxyethanol and ethylhexylglycerin very effective in penetrating the cell membranes of microorganisms, resulting in optimized antimicrobial efficacy.
- Microbiological Efficacy
New AE ProTek® NPB has a broad spectrum efficacy against Gram Positive, Gram Negative, Yeast, and Fungi.
Applications & Uses
- Markets
- Applications
- Skin Care Applications
- Use Level
- 0.5 - 1.0%
- User Guide
- Emulsions: Use at the level of 0.5% to 1.0%, New AE Protek®NPB can be added both in the hot or cold stages of production.
- Clear Solutions: New AE Protek®NPB is soluble at levels up to 1.0% and therefore can make clear products.
- Wet wipes: New AE Protek®NPB offers good preservation results at 0.5% to 1.0% use levels.
Properties
- Physical Form
- Appearance
- Clear liquid
- Odor
- Characteristic
- Typical Properties
- Physico-Chemical Properties
- Microbiological Values
| Value | Units | Test Method / Conditions | |
| pH Range | max. 12 | — | — |
| Value | Units | Test Method / Conditions | |
| Density | approx 1.09 | g/ml | — |
| Flash Point | min. 100 | ºC | DIN 51 758 |
| Refractive Index | approx. 1.53 | — | — |
| Vapour Pressure (at 25°C) | <1 hPa | hPa | — |
| Viscosity (Brookfield RVT) | 68 | mPa s | — |
| Water Solubility (at 25ºC / 60ºC) | approx. (10 / 15) | g/L | — |
| Value | Units | Test Method / Conditions | |
| Aspergillus niger | min. 0.15 | % | — |
| Burkholderia cepacia | min. 0.2 | % | — |
| Candida albican | min. 0.15 | % | — |
| Enterobacter cloacae | min. 0.25 | % | — |
| Escherichia coli | min. 0.3 | % | — |
| Klebisella pneumonia | min. 0.25 | % | — |
| Penicillium funiculosum | min. 0.15 | % | — |
| Pseudomonas aeruginosa | min. 0.3 | % | — |
| Pseudomonas fluorescens | min. 0.2 | % | — |
| Pseudomonas putida | min. 0.2 | % | — |
| Staphylococcus aureus | min. 0.25 | % | — |
| Staphylococcus epidermidis | min. 0.25 | % | — |
Regulatory & Compliance
- Worldwide Approval
Approved for use in Japan, Canada, and Australia